{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:42:36Z","timestamp":1789425756977,"version":"build-2803163510"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.tripleo.2006.11.002","type":"journal-article","created":{"date-parts":[[2007,3,21]],"date-time":"2007-03-21T10:52:47Z","timestamp":1174474367000},"page":"S50.e1-S50.e23","source":"Crossref","is-referenced-by-count":39,"special_numbering":"S","title":["Management of oral lesions in HIV-positive patients"],"prefix":"10.1016","volume":"103","author":[{"given":"Lorena","family":"Baccaglini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren L.","family":"Patton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Glick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ficarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2006.11.002_bib1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS) and World Health Organization (WHO). AIDS epidemic update: December 2005. WHO Library Cataloguing-in-Publication Data. 2005. Available at: http:\/\/www.unaids.org. Accessed May 25, 2006."},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib2","first-page":"121","article-title":"Racial\/ethnic disparities in diagnosis of HIV\/AIDS\u201433 states, 2001-2004","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tripleo.2004.06.081","article-title":"Incidence of oral candidiasis and oral hairy leukoplakia in HIV-infected adults in North Carolina","volume":"99","author":"Chattopadhyay","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00042560-200009010-00006","article-title":"Oral mucosal lesions and HIV viral load in the Women\u2019s Interagency HIV Study (WIHS)","volume":"25","author":"Greenspan","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/154405910408300212","article-title":"Incidence of oral lesions in HIV-1-infected women: reduction with HAART","volume":"83","author":"Greenspan","year":"2004","journal-title":"J Dent Res"},{"issue":"7","key":"10.1016\/j.tripleo.2006.11.002_bib6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1034\/j.1600-0714.2000.290708.x","article-title":"Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy","volume":"29","author":"Schmidt-Westhausen","year":"2000","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00005792-200301000-00004","article-title":"The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1,000 consecutive patients: a 12-year study in a referral center in Mexico","volume":"82","author":"Ramirez-Amador","year":"2003","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1079-2104(00)70092-8","article-title":"Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy","volume":"89","author":"Patton","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"9266","key":"10.1016\/j.tripleo.2006.11.002_bib9","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(00)04578-5","article-title":"Effect of highly active antiretroviral therapy on frequency of oral warts","volume":"357","author":"Greenspan","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0030-4220(94)90195-3","article-title":"Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS","volume":"77","author":"Glick","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0528.2004.00194.x","article-title":"Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults","volume":"33","author":"Chattopadhyay","year":"2005","journal-title":"Community Dent Oral Epidemiol"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1067\/moe.2000.108799","article-title":"Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV\/AIDS as markers of immune suppression and viral burden","volume":"90","author":"Patton","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/tropej\/49.3.143","article-title":"Evaluation of the WHO clinical case definition for pediatric HIV infection in Bloemfontein, South Africa","volume":"49","author":"van Gend","year":"2003","journal-title":"J Trop Pediatr"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.inf.0000207400.93627.4c","article-title":"Comorbidities and mortality among children hospitalized with diarrheal disease in an area of high prevalence of human immunodeficiency virus infection","volume":"25","author":"Chhagan","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.tripleo.2006.11.002_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/apc.1998.12.625","article-title":"The treatment of oropharyngeal candidiasis in HIV-infected patients with oral amphotericin B suspension","volume":"12","author":"Hood","year":"1998","journal-title":"AIDS Patient Care Stds"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)00307-0","article-title":"Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV\/AIDS patients","volume":"104","author":"Graybill","year":"1998","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9343(98)00137-5","article-title":"A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance","volume":"105","author":"Revankar","year":"1998","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01191-9","article-title":"A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis","volume":"113","author":"Villanueva","year":"2002","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.tripleo.2006.11.002_bib19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-126-9-199705010-00003","article-title":"Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection","volume":"126","author":"Schuman","year":"1997","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.tripleo.2006.11.002_bib20","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.34.11.2267","article-title":"Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus","volume":"34","author":"Koletar","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"6859","key":"10.1016\/j.tripleo.2006.11.002_bib21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/bmj.305.6859.921","article-title":"Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis","volume":"305","author":"Chavanet","year":"1992","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib22","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1086\/513664","article-title":"Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions","volume":"24","author":"Pons","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib23","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516342","article-title":"A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS","volume":"26","author":"Phillips","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1086\/515149","article-title":"Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870","volume":"28","author":"Hood","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"RR-14","key":"10.1016\/j.tripleo.2006.11.002_bib25","first-page":"1","article-title":"Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America","volume":"53","author":"Mofenson","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.tripleo.2006.11.002_bib26","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1086\/497373","article-title":"A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323\/Mycoses Study Group Study 40","volume":"41","author":"Goldman","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0149-2918(97)80131-2","article-title":"Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients","volume":"19","author":"Murray","year":"1997","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3201\/eid0502.990214","article-title":"Evaluating diagnosis and treatment of oral and esophageal candidiasis in Ugandan AIDS patients","volume":"5","author":"Ravera","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.tripleo.2006.11.002_bib29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00228-001-0377-6","article-title":"Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients","volume":"57","author":"Csajka","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.tripleo.2006.11.002_bib30","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-4362.2000.00087.x","article-title":"Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients","volume":"39","author":"Linpiyawan","year":"2000","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00042560-199608150-00005","article-title":"Prophylaxis with nystatin pastilles for HIV-associated oral candidiasis","volume":"12","author":"MacPhail","year":"1996","journal-title":"J Acquir Immune Def Syndr Hum Retrovir"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00126334-200402010-00007","article-title":"Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis","volume":"35","author":"Van","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jac\/dkf101","article-title":"Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial","volume":"50","author":"Pagani","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.tripleo.2006.11.002_bib34","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1128\/JCM.33.10.2732-2737.1995","article-title":"Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities","volume":"33","author":"Le","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.tripleo.2006.11.002_bib35","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1128\/JCM.36.8.2308-2313.1998","article-title":"Random amplification of polymorphic DNA and microsatellite genotyping of pre- and posttreatment isolates of Candida spp. from human immunodeficiency virus-infected patients on different fluconazole regimens","volume":"36","author":"Metzgar","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"RR-15","key":"10.1016\/j.tripleo.2006.11.002_bib36","first-page":"1","article-title":"Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America","volume":"53","author":"Benson","year":"2004","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"10.1016\/j.tripleo.2006.11.002_bib37","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199503163321102","article-title":"A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection","volume":"332","author":"Powderly","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1067\/moe.2001.116600","article-title":"A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients","volume":"92","author":"Patton","year":"2001","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tripleo.2003.09.005","article-title":"Efficacy of chlorhexidine gluconate rinse for treatment and prevention of oral candidiasis in HIV-infected children: a pilot study","volume":"97","author":"Barasch","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib40","first-page":"45","article-title":"Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients","volume":"72","author":"Nyst","year":"1992","journal-title":"Ann Soc Belge Med Trop"},{"issue":"11","key":"10.1016\/j.tripleo.2006.11.002_bib41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/BF02005444","article-title":"Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients","volume":"10","author":"Just-Nubling","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0163-4453(90)90646-P","article-title":"Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study","volume":"21","author":"Leen","year":"1990","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5694\/j.1326-5377.1993.tb121784.x","article-title":"Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients","volume":"158","author":"Marriott","year":"1993","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(94)90300-X","article-title":"Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance","volume":"97","author":"Sangeorzan","year":"1994","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.tripleo.2006.11.002_bib45","first-page":"1311","article-title":"Therapy for oropharyngeal candidiasis in HIV-infected patients: A randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches","volume":"6","author":"Pons","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.tripleo.2006.11.002_bib46","first-page":"1317","article-title":"Therapy for oropharyngeal candidiasis in HIV-infected patients","volume":"6","author":"Glatt","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000239469","article-title":"Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis","volume":"42","author":"de Repentigny","year":"1996","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00002030-199706000-00009","article-title":"A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis","volume":"11","author":"De Wit","year":"1997","journal-title":"Aids"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/030006059802600307","article-title":"Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis","volume":"26","author":"De Wit","year":"1998","journal-title":"J Int Med Res"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1742-1241.1999.tb11744.x","article-title":"A randomised, double-blind study of itraconazole versus placebo in the treatment and prevention of oral or oesophageal candidosis in patients with HIV infection","volume":"53","author":"Smith","year":"1999","journal-title":"Int J Clin Pract"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/j.1875-595X.1999.tb00795.x","article-title":"Clinical management of selected oral fungal and viral infections during HIV-disease","volume":"49","author":"Reichart","year":"1999","journal-title":"Int Dent J"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1754-4505.1992.tb00402.x","article-title":"A comparison between fluconazole tablets and clotrimazole troches for the treatment of thrush in HIV infection","volume":"12","author":"Redding","year":"1992","journal-title":"Spec Care Dentist"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib53","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1310\/99DY-8Q52-306A-V0AJ","article-title":"Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS","volume":"3","author":"Vazquez","year":"2002","journal-title":"HIV Clin Trials"},{"issue":"11","key":"10.1016\/j.tripleo.2006.11.002_bib54","first-page":"457","article-title":"A systematic review of the management of oral candidiasis associated with HIV\/AIDS","volume":"57","author":"Albougy","year":"2002","journal-title":"SADJ"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib55","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jac\/dki473","article-title":"Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?","volume":"57","author":"Charlier","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib56","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1086\/314887","article-title":"Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization","volume":"180","author":"Gottfredsson","year":"1999","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.tripleo.2006.11.002_bib57","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/1087291041703665","article-title":"Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity","volume":"18","author":"Leigh","year":"2004","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib58","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1128\/IAI.73.6.3659-3667.2005","article-title":"Characterization of CD8+ T cells and microenvironment in oral lesions of human immunodeficiency virus-infected persons with oropharyngeal candidiasis","volume":"73","author":"McNulty","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.tripleo.2006.11.002_bib59","first-page":"1701","article-title":"Candidiasis (oropharyngeal)","volume":"13","author":"Pankhurst","year":"2005","journal-title":"Clin Evid"},{"issue":"9-10","key":"10.1016\/j.tripleo.2006.11.002_bib60","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1439-0507.2004.01019.x","article-title":"Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics","volume":"47","author":"Schmidt-Westhausen","year":"2004","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00002018-199818020-00001","article-title":"Systemic antifungal agents","volume":"18","author":"Albengres","year":"1998","journal-title":"Drug Saf"},{"issue":"no. RR-15","key":"10.1016\/j.tripleo.2006.11.002_bib62","first-page":"1","article-title":"Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association\/Infectious Diseases Society of America","volume":"54","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.femsim.2003.12.006","article-title":"Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility","volume":"41","author":"De Bernardis","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"7","key":"10.1016\/j.tripleo.2006.11.002_bib64","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/00002030-200005050-00011","article-title":"Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection","volume":"14","author":"Fichtenbaum","year":"2000","journal-title":"AIDS"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.11.002_bib65","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/427295","article-title":"Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America","volume":"40","author":"Mofenson","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"no. RR-14","key":"10.1016\/j.tripleo.2006.11.002_bib66","first-page":"1","article-title":"Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America","volume":"53","year":"2004","journal-title":"MMWR"},{"issue":"12","key":"10.1016\/j.tripleo.2006.11.002_bib67","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/archderm.128.12.1659","article-title":"Treatment of oral hairy leukoplakia with podophyllin","volume":"128","author":"Sanchez","year":"1992","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib68","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/378072","article-title":"Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir","volume":"188","author":"Walling","year":"2003","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib69","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0030-4220(92)90097-A","article-title":"Retrospective findings of the clinical benefits of podophyllum resin 25% sol on hairy leukoplakia","volume":"73","author":"Lozada-Nur","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib70","first-page":"571","article-title":"Efficacy of desciclovir in the treatment of Epstein-Barr virus infection in oral hairy leukoplakia","volume":"3","author":"Greenspan","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib71","first-page":"543","article-title":"Podophyllin resin 25% for treatment of oral hairy leukoplakia: an old treatment for a new lesion","volume":"4","author":"Lozada-Nur","year":"1991","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib72","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1079-2104(05)80076-9","article-title":"Treatment of HIV-related hairy leukoplakia with podophyllum resin 25% solution","volume":"79","author":"Gowdey","year":"1995","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"4 Pt 1","key":"10.1016\/j.tripleo.2006.11.002_bib73","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0190-9622(89)70250-4","article-title":"Comparison of the efficacy of surgery and acyclovir therapy in oral hairy leukoplakia","volume":"21","author":"Herbst","year":"1989","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib74","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000249008","article-title":"Treatment of oral \u2019hairy\u2019 leukoplakia in AIDS patients with vitamin A acid (topically) or acyclovir (systemically)","volume":"174","author":"Schofer","year":"1987","journal-title":"Dermatologica"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib75","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jama.259.3.384","article-title":"Regression of oral hairy leukoplakia after orally administered acyclovir therapy","volume":"259","author":"Resnick","year":"1988","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.tripleo.2006.11.002_bib76","first-page":"1014","article-title":"Resolution of oral hairy leukoplakia during treatment with foscarnet","volume":"8","author":"Albrecht","year":"1994","journal-title":"Aids"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib77","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-107-2-348","article-title":"Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG)","volume":"107","author":"Newman","year":"1987","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/15563658208990364","article-title":"Podophyllum toxicity: a report of a fatal case and a review of the literature","volume":"19","author":"Cassidy","year":"1982","journal-title":"J Toxicol Clin Toxicol"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib79","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2133.2005.07038.x","article-title":"Efficacy of famciclovir in the treatment of oral hairy leukoplakia","volume":"154","author":"Pastore","year":"2006","journal-title":"Br J Dermatol"},{"issue":"15","key":"10.1016\/j.tripleo.2006.11.002_bib80","doi-asserted-by":"crossref","first-page":"10040","DOI":"10.1128\/JVI.79.15.10040-10052.2005","article-title":"Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1","volume":"79","author":"Hahn","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib81","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1399-302X.2005.00198.x","article-title":"Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions","volume":"20","author":"Lilly","year":"2005","journal-title":"Oral Microbiol Immunol"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib82","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/378072","article-title":"Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir","volume":"188","author":"Walling","year":"2003","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.tripleo.2006.11.002_bib83","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00128071-200304100-00002","article-title":"Management strategies for HIV-associated aphthous stomatitis","volume":"4","author":"Kerr","year":"2003","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib84","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1086\/515222","article-title":"Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial","volume":"28","author":"Ramirez-Amador","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib85","doi-asserted-by":"crossref","first-page":"591","DOI":"10.14219\/jada.archive.2002.0234","article-title":"Laser palliation of oral manifestations of human immunodeficiency virus infection","volume":"133","author":"Convissar","year":"2002","journal-title":"J Am Dent Assoc"},{"issue":"21","key":"10.1016\/j.tripleo.2006.11.002_bib86","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199705223362103","article-title":"Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection","volume":"336","author":"Jacobson","year":"1997","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib87","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1086\/317928","article-title":"Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers","volume":"183","author":"Jacobson","year":"2001","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.tripleo.2006.11.002_bib88","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1086\/340133","article-title":"Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267","volume":"185","author":"Wohl","year":"2002","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.tripleo.2006.11.002_bib89","first-page":"2163","article-title":"Comparison of two corticosteroid regimens for the treatment of HIV-associated idiopathic esophageal ulcer","volume":"89","author":"Wilcox","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.11.002_bib90","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1111\/j.1601-0825.1997.tb00358.x","article-title":"Oral ulceration in HIV infection: investigation and pathogenesis","volume":"3","author":"MacPhail","year":"1997","journal-title":"Oral Dis"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2133.2000.03263.x","article-title":"Successful treatment of aphthous ulcerations in AIDS patients using topical granulocyte-macrophage colony-stimulating factor","volume":"142","author":"Herranz","year":"2000","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1258\/095646204322764352","article-title":"Remission of Behcet\u2019s disease and keratoconjunctivitis sicca in an HIV-infected patient treated with HAART","volume":"15","author":"Cicalini","year":"2004","journal-title":"Int J STD AIDS"},{"issue":"7","key":"10.1016\/j.tripleo.2006.11.002_bib93","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.1992.0164","article-title":"Alternative therapies for major aphthous ulcers in AIDS patients","volume":"123","author":"Glick","year":"1992","journal-title":"J Am Dent Assoc"},{"issue":"10","key":"10.1016\/j.tripleo.2006.11.002_bib94","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00128071-200304100-00002","article-title":"Management strategies for HIV-associated aphthous stomatitis","volume":"4","author":"Kerr","year":"2003","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib95","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00002030-200202150-00014","article-title":"Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi\u2019s sarcoma","volume":"16","author":"Miles","year":"2002","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.tripleo.2006.11.002_bib96","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/01.aids.0000131385.60974.b9","article-title":"Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi\u2019s sarcoma","volume":"18","author":"Martin-Carbonero","year":"2004","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib97","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archderm.139.2.178","article-title":"9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial","volume":"139","author":"Aboulafia","year":"2003","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.tripleo.2006.11.002_bib98","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archotol.125.8.873","article-title":"Oral cavity and oropharyngeal tumors in human immunodeficiency virus-positive patients: acute response to radiation therapy","volume":"125","author":"Kao","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"11","key":"10.1016\/j.tripleo.2006.11.002_bib99","first-page":"3432","article-title":"AIDS-related Kaposi\u2019s sarcoma: a phase II study of liposomal doxorubicin","volume":"5","author":"Cheung","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s15010-005-4099-z","article-title":"Treatment of HIV-1-associated Kaposi\u2019s sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery","volume":"33","author":"Lichterfeld","year":"2005","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib101","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ijc.20606","article-title":"Treatment of AIDS-associated Kaposi\u2019s sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial","volume":"113","author":"Olweny","year":"2005","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib102","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1200\/JCO.20.1.153","article-title":"Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi\u2019s sarcoma: a phase I AIDS malignancy consortium study","volume":"20","author":"Cianfrocca","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib103","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/515621","article-title":"Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data","volume":"178","author":"Ioannidis","year":"1998","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib104","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0278-2391(96)90637-0","article-title":"Intralesional vinblastine injections for the treatment of oral Kaposi\u2019s sarcoma: report of 10 patients with 2-year follow-up","volume":"54","author":"McCormick","year":"1996","journal-title":"J Oral Maxillofac Surg"},{"issue":"8671","key":"10.1016\/j.tripleo.2006.11.002_bib105","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(89)91114-8","article-title":"Intralesional vinblastine for oral Kaposi sarcoma in HIV infection","volume":"2","author":"Epstein","year":"1989","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib106","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(02)00263-3","article-title":"Update on Kaposi\u2019s sarcoma and other HHV8 associated diseases","volume":"2","author":"Hengge","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib107","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1368-8375(01)00100-2","article-title":"Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi\u2019s sarcoma. A double blind, randomized clinical trial","volume":"38","author":"Ramirez-Amador","year":"2002","journal-title":"Oral Oncology"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib108","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0030-4220(93)90093-J","article-title":"Treatment of oral Kaposi\u2019s sarcoma with a sclerosing agent in AIDS patients","volume":"75","author":"Lucatorto","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib109","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.tripleo.2005.01.015","article-title":"Oral malignancies in HIV disease: changes in disease presentation, increasing understanding of molecular pathogenesis, and current management","volume":"100","author":"Epstein","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib110","first-page":"424","article-title":"Acquired immunodeficiency syndrome-related Kaposi\u2019s sarcoma: clinical features, staging, and treatment","volume":"27","author":"Dezube","year":"2000","journal-title":"Semin Oncol"},{"issue":"6 Suppl 13","key":"10.1016\/j.tripleo.2006.11.002_bib111","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.seminoncol.2004.08.003","article-title":"Use of liposomal anthracyclines in Kaposi\u2019s sarcoma","volume":"31","author":"Krown","year":"2004","journal-title":"Semin Oncol"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib112","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0964-1955(95)00009-7","article-title":"Role of intralesional vinblastine administration in treatment of intraoral Kaposi\u2019s sarcoma in AIDS","volume":"31B","author":"Flaitz","year":"1995","journal-title":"Eur J Cancer B Oral Oncol"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib113","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1445-5994.1998.tb01553.x","article-title":"A phase II study of liposomal doxorubicin in the treatment of HIV-related Kaposi\u2019s sarcoma","volume":"28","author":"Newell","year":"1998","journal-title":"Aust N Z J Med"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.11.002_bib114","first-page":"S66","article-title":"Therapy for Kaposi\u2019s sarcoma: recent advances and experimental approaches","volume":"21","author":"Yarchoan","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.tripleo.2006.11.002_bib115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ncponc0253","article-title":"Therapy insight: AIDS-related malignancies--the influence of antiviral therapy on pathogenesis and management","volume":"2","author":"Yarchoan","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"issue":"12","key":"10.1016\/j.tripleo.2006.11.002_bib116","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archderm.136.12.1461","article-title":"Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials","volume":"136","author":"Duvic","year":"2000","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.tripleo.2006.11.002_bib117","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi\u2019s sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria","volume":"7","author":"Krown","year":"1989","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib118","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0277-5379(89)90217-4","article-title":"Interferon administered intralesionally in skin and oral cavity lesions in heterosexual drug addicted patients with AIDS-related Kaposi\u2019s sarcoma","volume":"25","author":"Sulis","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"12","key":"10.1016\/j.tripleo.2006.11.002_bib119","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/blood.V93.12.4031","article-title":"Inflammatory reactivation and angiogenicity of Kaposi\u2019s sarcoma-associated herpesvirus\/HHV8: a missing link in the pathogenesis of acquired immunodeficiency syndrome-associated Kaposi\u2019s sarcoma","volume":"93","author":"Mesri","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib120","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2141.2005.05613.x","article-title":"AIDS-related lymphomas: from pathogenesis to pathology","volume":"130","author":"Carbone","year":"2005","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.tripleo.2006.11.002_bib121","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi\u2019s sarcoma: an AIDS Malignancy Consortium Study","volume":"24","author":"Dezube","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib122","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM199301213280312","article-title":"Sclerotherapy for the treatment of nodular intraoral Kaposi\u2019s sarcoma in patients with AIDS","volume":"328","author":"Muzyka","year":"1993","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib123","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jcv.2005.10.010","article-title":"Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study","volume":"35","author":"Mbulaiteye","year":"2006","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.tripleo.2006.11.002_bib124","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/00002030-200006160-00019","article-title":"Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals","volume":"14","author":"Romanowski","year":"2000","journal-title":"AIDS"},{"issue":"14","key":"10.1016\/j.tripleo.2006.11.002_bib125","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/00002030-200109280-00014","article-title":"Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"15","author":"Fagot","year":"2001","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-128-1-199801010-00004","article-title":"Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons","volume":"128","author":"Schacker","year":"1998","journal-title":"Ann Intern Med"},{"issue":"Suppl 5","key":"10.1016\/j.tripleo.2006.11.002_bib127","article-title":"Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV","volume":"39","author":"Warren","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib128","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2165\/00003495-200059040-00013","article-title":"Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections","volume":"59","author":"Ormrod","year":"2000","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.tripleo.2006.11.002_bib129","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1258\/0956462001916533","article-title":"A comparison of topical application of penciclovir 1% cream with acyclovir 3% cream for treatment of genital herpes: a randomized, double-blind, multicentre trial","volume":"11","author":"Chen","year":"2000","journal-title":"Int J STD AIDS"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1258\/0956462021924550","article-title":"Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials","volume":"13","author":"Conant","year":"2002","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib131","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1086\/516542","article-title":"A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS","volume":"176","author":"Lalezari","year":"1997","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.tripleo.2006.11.002_bib132","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1086\/345771","article-title":"Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression","volume":"186","author":"Schacker","year":"2002","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.11.002_bib133","article-title":"Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years\u2019 experience with acyclovir","volume":"186","author":"Tyring","year":"2002","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.tripleo.2006.11.002_bib134","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1086\/378416","article-title":"Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects","volume":"188","author":"DeJesus","year":"2003","journal-title":"J Infect Dis"},{"issue":"8780","key":"10.1016\/j.tripleo.2006.11.002_bib135","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0140-6736(91)92723-F","article-title":"Prevention of ultraviolet-light-induced herpes labialis by sunscreen","volume":"338","author":"Rooney","year":"1991","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.tripleo.2006.11.002_bib136","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM199108223250805","article-title":"A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome","volume":"325","author":"Safrin","year":"1991","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib137","first-page":"669","article-title":"A double-blind randomized placebo trial on very high doses of acyclovir in weakly symptomatic HIV-patients","volume":"14","author":"Chavanet","year":"1990","journal-title":"Cancer Detect Prev"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib138","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00002030-199405000-00010","article-title":"Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study","volume":"8","author":"Youle","year":"1994","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib139","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000080214","article-title":"Penciclovir cream\u2014improved topical treatment for herpes simplex infections","volume":"17","author":"Schmid-Wendtner","year":"2004","journal-title":"Skin Pharmacol Physiol"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib140","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-125-5-199609010-00004","article-title":"Acyclovir with and without prednisone for the treatment of herpes zoster","volume":"125","author":"Whitley","year":"1996","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.tripleo.2006.11.002_bib141","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","article-title":"Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults","volume":"39","author":"Beutner","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib142","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1128\/AAC.42.5.1139","article-title":"Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial","volume":"42","author":"Gnann","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib143","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1086\/515045","article-title":"Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy","volume":"27","author":"Breton","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib144","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/acm.1999.5.553","article-title":"Evaluating herbal medicine for the management of Herpes zoster in human immunodeficiency virus-infected patients in Kampala, Uganda","volume":"5","author":"Homsy","year":"1999","journal-title":"J Altern Complement Med"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/514011","article-title":"Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults","volume":"176","author":"Bodsworth","year":"1997","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib146","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3959(95)00146-8","article-title":"Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia","volume":"65","author":"Rowbotham","year":"1996","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib147","article-title":"Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population","volume":"11","author":"Bravo","year":"2006","journal-title":"Med Oral Pathol Oral Cir Bucal"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.11.002_bib148","first-page":"36A","article-title":"The interaction between herpes simplex virus and human immunodeficiency virus","volume":"11","author":"Celum","year":"2004","journal-title":"Herpes"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib149","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1097\/00126334-200412150-00013","article-title":"Herpes zoster in women with and at risk for HIV: data from the Women\u2019s Interagency HIV Study","volume":"37","author":"Glesby","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"10.1016\/j.tripleo.2006.11.002_bib150","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1258\/095646205774357271","article-title":"Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study","volume":"16","author":"Hung","year":"2005","journal-title":"Int J STD AIDS"},{"issue":"2","key":"10.1016\/j.tripleo.2006.11.002_bib151","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.qai.0000178408.62675.b0","article-title":"The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era","volume":"40","author":"Gebo","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"17","key":"10.1016\/j.tripleo.2006.11.002_bib152","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1097\/00002030-199912030-00011","article-title":"A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients","volume":"13","author":"Gilson","year":"1999","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib153","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00002030-200202150-00017","article-title":"Combined surgery and cidofovir is an effective treatment for genital warts in HIV-infected patients","volume":"16","author":"Orlando","year":"2002","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib154","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000441-200407000-00008","article-title":"Human papillomavirus infection and disease in HIV-infected individuals","volume":"328","author":"Hagensee","year":"2004","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.tripleo.2006.11.002_bib155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2334-1-3","article-title":"Imiquimod for the treatment of genital warts: a quantitative systematic review","volume":"1","author":"Moore","year":"2001","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib156","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1365-2133.2005.06461.x","article-title":"Refractory human papillomavirus-associated oral warts treated topically with 1-3% cidofovir solutions in human immunodeficiency virus type 1-infected patients","volume":"152","author":"Husak","year":"2005","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib157","first-page":"191","article-title":"The management of oral human papillomavirus with topical cidofovir: a case report","volume":"73","author":"DeRossi","year":"2004","journal-title":"Cutis"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib158","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/014556130508400513","article-title":"Use of a powered shaver to remove multiple oral cavity papillomas","volume":"84","author":"Miller","year":"2005","journal-title":"Ear Nose Throat J"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib159","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0190-9622(95)90192-2","article-title":"Guidelines of care for warts: human papillomavirus","volume":"32","author":"Drake","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/infdis\/162.1.52","article-title":"A randomized trial of combination therapy with intralesional interferon alpha 2b and podophyllin versus podophyllin alone for the therapy of anogenital warts","volume":"162","author":"Douglas","year":"1990","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib161","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/moe.2001.118905","article-title":"Use of intralesional interferon-alpha for the treatment of recalcitrant oral warts in patients with AIDS: a report of 4 cases","volume":"92","author":"Lozada-Nur","year":"2001","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib162","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00007435-200106000-00007","article-title":"Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons","volume":"28","author":"Matteelli","year":"2001","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.tripleo.2006.11.002_bib163","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/01.olq.0000175398.34610.2e","article-title":"The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults","volume":"32","author":"Cameron","year":"2005","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib164","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1468-3083.2000.00184.x","article-title":"Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV\/AIDS","volume":"14","author":"Calista","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1468-3083.2000.00094-7.x","article-title":"Treatment of oral condylomata acuminata in a HIV-1 patient with bleomycin","volume":"14","author":"Girao","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib166","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1754-4505.1991.tb01527.x","article-title":"Minimizing risk of infection using a carbon dioxide laser","volume":"11","author":"Miller","year":"1991","journal-title":"Spec Care Dentist"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib167","first-page":"459","article-title":"Combined medical and surgical management of intraoral condyloma acuminata","volume":"39","author":"Marquard","year":"1981","journal-title":"J Oral Surg"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib168","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1440-0960.1996.tb01035.x","article-title":"Cimetidine for mucosal warts in an HIV positive adult","volume":"37","author":"Wargon","year":"1996","journal-title":"Australas J Dermatol"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib169","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0002-9440(10)63334-2","article-title":"Highly tissue substructure-specific effects of human papilloma virus in mucosa of HIV-infected patients revealed by laser-dissection microscopy-assisted gene expression profiling","volume":"165","author":"Baumgarth","year":"2004","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000441-200407000-00008","article-title":"Human papillomavirus infection and disease in HIV-infected individuals","volume":"328","author":"Hagensee","year":"2004","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib171","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2340\/0001555574393395","article-title":"Polymerase chain reaction for monitoring human papillomavirus contamination of medical personnel during treatment of genital warts with CO2 laser and electrocoagulation","volume":"74","author":"Bergbrant","year":"1994","journal-title":"Acta Derm Venereol"},{"issue":"Suppl 2","key":"10.1016\/j.tripleo.2006.11.002_bib172","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1034\/j.1601-0825.2002.00019.x","article-title":"The significance and management of periodontal lesions in HIV infection","volume":"8","author":"Robinson","year":"2002","journal-title":"Oral Dis"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.11.002_bib173","article-title":"Periodontal health and HIV infection","volume":"3","author":"Robinson","year":"1997","journal-title":"Oral Dis"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib174","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-051X.1998.tb02437.x","article-title":"Gingival ulceration in HIV infection","volume":"25","author":"Robinson","year":"1998","journal-title":"J Clin Periodontol"},{"issue":"6","key":"10.1016\/j.tripleo.2006.11.002_bib175","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1902\/jop.1998.69.6.710","article-title":"Rapid progression of bone loss in HIV-associated necrotizing ulcerative stomatitis","volume":"69","author":"Patton","year":"1998","journal-title":"J Periodontol"},{"issue":"5","key":"10.1016\/j.tripleo.2006.11.002_bib176","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1902\/jop.1994.65.5.393","article-title":"Necrotizing ulcerative periodontitis: a marker for immune deterioration and a predictor for the diagnosis of AIDS","volume":"65","author":"Glick","year":"1994","journal-title":"J Periodontol"},{"issue":"10","key":"10.1016\/j.tripleo.2006.11.002_bib177","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1600-051X.1992.tb02173.x","article-title":"Periodontal changes by HIV serostatus in a cohort of homosexual and bisexual men","volume":"19","author":"Barr","year":"1992","journal-title":"J Clin Periodontol"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib178","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1600-051x.2000.027004273.x","article-title":"A controlled study of relative periodontal attachment loss in people with HIV infection","volume":"27","author":"Robinson","year":"2000","journal-title":"J Clin Periodontol"},{"issue":"7","key":"10.1016\/j.tripleo.2006.11.002_bib179","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1902\/jop.1993.64.7.651","article-title":"Progression of periodontal disease in HIV seropositive patients","volume":"64","author":"Yeung","year":"1993","journal-title":"J Periodontol"},{"issue":"3","key":"10.1016\/j.tripleo.2006.11.002_bib180","first-page":"215","article-title":"Oral soft tissue manifestations in HIV-positive vs","volume":"22","author":"Barasch","year":"2000","journal-title":"Pediatr Dent"},{"issue":"4","key":"10.1016\/j.tripleo.2006.11.002_bib181","first-page":"287","article-title":"Prevalence of oral soft tissue lesions in HIV-infected minority children treated with highly active antiretroviral therapies","volume":"22","author":"Flanagan","year":"2000","journal-title":"Pediatr Dent"},{"issue":"Suppl 2","key":"10.1016\/j.tripleo.2006.11.002_bib182","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1034\/j.1601-0825.2002.00019.x","article-title":"The significance and management of periodontal lesions in HIV infection","volume":"8","author":"Robinson","year":"2002","journal-title":"Oral Dis"},{"issue":"1","key":"10.1016\/j.tripleo.2006.11.002_bib183","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1902\/annals.2002.7.1.8","article-title":"Bacterial diversity in necrotizing ulcerative periodontitis in HIV-positive subjects","volume":"7","author":"Paster","year":"2002","journal-title":"Ann Periodontol"},{"issue":"10","key":"10.1016\/j.tripleo.2006.11.002_bib184","first-page":"448","article-title":"Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy","volume":"10","author":"Kroidl","year":"2005","journal-title":"Eur J Med Res"},{"issue":"18","key":"10.1016\/j.tripleo.2006.11.002_bib185","first-page":"706","article-title":"Necrotizing periodontal disease: a manifestation of systemic disorders","volume":"125","author":"Bascones-Martinez","year":"2005","journal-title":"Med Clin (Barc)"},{"issue":"3 Suppl","key":"10.1016\/j.tripleo.2006.11.002_bib186","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1097\/01.PCC.0000161579.39050.6B","article-title":"Sepsis predisposition in children with human immunodeficiency virus","volume":"6","author":"Hatherill","year":"2005","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"10.1016\/j.tripleo.2006.11.002_bib187","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/apc.2005.19.635","article-title":"Recrudescent Kaposi\u2019s sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome","volume":"19","author":"Leidner","year":"2005","journal-title":"AIDS Patient Care STDS"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210406008614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210406008614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T08:24:47Z","timestamp":1707726287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210406008614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":187,"alternative-id":["S1079210406008614"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2006.11.002","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}